Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
These are the latest cancer treatments approved by the FDA.
Data from a large COVID-19 and cancer registry also showed that hydroxychloroquine plus azithromycin is associated with higher mortality.
Ramucirumab slowed disease progression more than a placebo when added to erlotinib.
Here’s a list of the approved drugs to treat lung cancer. Click on any of the medications for more info on dosing, side effects and d...
Study showed 74% overall response rate for people who used brigatinib as their first ALK inhibitor.
Initial treatment with atezolizumab led to longer overall survival in people with high biomarker levels.
The combination led to improved overall survival compared with chemotherapy.
Selpercatinib, the first drug in its class, shrank tumors in over two thirds of previously treated patients.
Capmatinib shrank tumors in 68% of people with metastatic non-small-cell lung cancer with a specific MET mutation.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.